Travel-Acquired Illnesses
Sources of Information
The Centers for Disease Control and Prevention (CDC) publishes several authoritative sources of information on travel medicine. Health Information for International Travel (the “yellow book”) is updated annually. Two other periodicals, the weekly Morbidity and Mortality Weekly Report (MMWR) and Summary of Health Information for International Travel (the “blue sheet,” published biweekly), provide updated information on the status of immunization recommendations, worldwide disease outbreaks, and changes in health conditions. A reliable way to obtain current travel health information, including vaccine requirements, malaria chemoprophylaxis, and disease outbreaks for various regions of the world, is to consult the CDC Travelers’ Health website at http://wwwnc.cdc.gov/travel/. See Chapter 49 for more information on immunizations for travel. For nonmedical information of interest to the traveler, the U.S. State Department can be accessed at http://travel.state.gov/. Additional resources for travel medicine information are listed at the end of the chapter.
Aside from traveler’s diarrhea (see Chapter 44), traffic-related accidents, and purified protein derivative conversion, the major travel-acquired illnesses in descending order from most to least common are as follows:
Dengue Fever
Signs and Symptoms (Compare Dengue With Malaria in Table 48-1)
Table 48-1
Clinical Illness in Malaria and Dengue Fever
SIGNS AND SYMPTOMS | MALARIA | DENGUE FEVER |
Fever | +++ | +++ |
Chills | +++ | ++ |
Headache | +++ | +++ |
Malaise | ++ | |
Anorexia | ++ | |
Nausea, vomiting | ++ | ++ |
Abdominal pain | ++ | |
Myalgia | ++ | ++ |
Arthralgia | ++ | |
Backache | + | |
Dark urine | + |
+++, >90% of patients; ++, >50% of patients; +, <10% of patients.
1. Clinically, may range from undifferentiated viral symptoms with fever and mild respiratory/gastrointestinal symptoms to dengue hemorrhagic fever
2. Incubation period: 4 to 6 days, although may be as long as 14 days
3. Early prodromal symptoms of fever (temperature usually greater than 39° C [102.2° F]), myalgias, headache, arthralgias, and rash. May also have gastrointestinal symptoms of nausea and vomiting
4. After several days, often maculopapular or morbilliform rash spreading outward from chest
5. Dengue can progress to severe forms, referred to as dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Severe DHF/DSS may progress to circulatory failure with shock and spontaneous bleeding from almost any site, most commonly the skin, nose, and gastrointestinal tract
6. After infection, patients often develop extreme fatigue persisting for weeks or months
7. DHF/DSS is unlikely in travelers not previously infected with dengue
8. Awareness of the local epidemiology of DHF/DSS is important in establishing the diagnosis. Definitive diagnosis of all forms requires serologic examination (antibody identification via enzyme-linked immunosorbent assay [ELISA] or polymerase chain reaction [PCR]) or viral isolation from serum
9. Predictors of more severe disease manifestations, including DHF/DSS, include serotype (DEN-2 is the most severe), prior exposure, age, malnutrition, and genetic factors such as human leukocyte antigen (HLA) type
Treatment
2. Administer acetaminophen for fever and myalgias (do not use salicylates).
3. Provide aggressive fluid and electrolyte resuscitation.
4. Be aware that severe DHF or any DSS is a medical emergency and requires immediate evacuation and hospitalization.
5. No specific therapy exists for any form of dengue.
6. Vaccine initiatives are ongoing; however, no licensed vaccine against dengue viruses currently exists.
Yellow Fever
Signs and Symptoms
1. May appear as an undifferentiated viral syndrome
2. Specific diagnosis in the wilderness is extremely difficult; clinical suspicion is based on immune status, geographic distribution of the disease, travel history, and characteristic triphasic fever, as follows:
a. Infection phase: After 3 to 6 days of incubation period, onset of headache, photophobia, fever, malaise, back pain, epigastric pain, anorexia, and vomiting. May also have “Faget sign” (bradycardia occurring at the height of the fever), conjunctival injection, and a coated tongue with pink edges
b. Remission phase: The 3 to 4 days of infection phase is followed by up to 48 hours of brief remission
c. Intoxication phase (up to 15% of individuals infected with yellow fever virus): Onset of jaundice, fever, encephalopathy, and in severe cases, hypotension, shock, oliguria, coma, and multiorgan failure. Hemorrhage usually manifested as hematemesis, but bleeding from multiple sites possible
d. Signs of a poor prognosis include early onset of the intoxication phase, hypotension, severe hemorrhage with disseminated intravascular coagulation, renal failure, shock, and coma
Treatment
1. Perform a careful physical examination. Be aware that the laboratory evaluation includes thick and thin blood smears to rule out malaria and blood cultures for bacterial pathogens; both of these necessitate evacuation to a qualified medical facility. If the patient’s condition progresses to the intoxication phase, arrange for immediate evacuation to an intensive care unit (ICU).
2. Note that no effective antiviral treatment is available for yellow fever.
Prevention
1. Give yellow fever vaccine (>95% of those vaccinated achieve significant antibody levels). Be aware that booster doses of vaccine are recommended every 10 years.
2. Current recommendations for yellow fever vaccine can be obtained online at http://wwwnc.cdc.gov/travel/ (see Chapter 49).
3. Avoid the causative organism through mosquito protection measures in endemic areas, including repellent and proper netting.
Rabies Exposure
Rabies exists almost everywhere in the world with the exception of Antarctica and a few island nations. Most cases of human disease in the developing world result from multiple, deep bites to the face, scalp, or upper extremities from an unimmunized canine. In more developed countries, however, the majority of rabies transmission occurs from wild animal carriers (see Chapter 42). Travelers who plan on spending more than 1 month in regions at high risk for rabies should consider preexposure rabies immunization. CDC recommendations for rabies prophylaxis can be found at http://www.cdc.gov/diseases/rabies.html. Rabies is almost universally fatal within a few weeks of symptom onset. If a potential rabies exposure occurs, immunized patients will require only two subsequent rabies immunization boosters on days 0 and 3 post exposure with close follow up. Patients without preexposure immunizations should receive rabies immune globulin and rabies immunization as outlined in Chapter 43.
Hepatitis Viruses
Hepatitis A
Signs and Symptoms
1. Incubation period ranging from 2 to 7 weeks
2. Infection is often asymptomatic or mild, especially in children
3. Classic syndrome: early onset of anorexia, followed by nausea, vomiting, fever, and abdominal pain
4. Symptoms possibly accompanied by hepatosplenomegaly